Xi B. Jin

270 Dong An Road
Shanghai, 200032, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 67 publications

HEBP2-governed glutamine competition between tumor and macrophages dictates immunotherapy efficacy in triple-negative breast cancer.

HEBP2-governed glutamine competition between tumor and macrophages dictates immunotherapy efficacy in triple-negative breast cancer.

Journal: Cell metabolism

Published: July 30, 2026

NK Cell Activation by Platinum Boosts Immunotherapy in HR+/HER2- Breast Cancer.

NK Cell Activation by Platinum Boosts Immunotherapy in HR+/HER2- Breast Cancer.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: September 26, 2025

Interferon-induced senescent CD8+ T cells reduce anti-PD1 immunotherapy efficacy in early triple-negative breast cancer.

Interferon-induced senescent CD8+ T cells reduce anti-PD1 immunotherapy efficacy in early triple-negative breast cancer.

Journal: Science translational medicine

Published: September 10, 2025

Obstructive sleep apnea increases high-shear whole blood viscosity and Plasma Viscosity in adults.

Obstructive sleep apnea increases high-shear whole blood viscosity and Plasma Viscosity in adults.

Journal: Clinical hemorheology and microcirculation

Published: July 14, 2025

Sitravatinib plus tislelizumab in locally recurrent or metastatic triple-negative breast cancer: a multi-cohort, single-arm, phase II clinical trial (SPARK Trial).

Sitravatinib plus tislelizumab in locally recurrent or metastatic triple-negative breast cancer: a multi-cohort, single-arm, phase II clinical trial (SPARK Trial).

Journal: Molecular cancer

Published: April 28, 2025

Discovery of Universal Phonon Thermal Hall Effect in Crystals.

Discovery of Universal Phonon Thermal Hall Effect in Crystals.

Journal: Physical review letters

Published: April 21, 2025

Nanosized Membrane Fusion-Triggered Three-Dimensional DNA Walker for Subtype-Specific Analysis of Breast Cancer Extracellular Vesicles.

Nanosized Membrane Fusion-Triggered Three-Dimensional DNA Walker for Subtype-Specific Analysis of Breast Cancer Extracellular Vesicles.

Journal: Nano letters

Published: March 25, 2025

Landscape of gene fusions in hormone receptor-positive breast cancer reveals ADK fusions as drivers of progression and potential therapeutic targets.

Landscape of gene fusions in hormone receptor-positive breast cancer reveals ADK fusions as drivers of progression and potential therapeutic targets.

Journal: Cell discovery

Published: March 14, 2025

Precision treatment with artificial intelligence assisted subtyping enhances therapeutic efficacy in HR+/HER2- breast cancer: The LINUXtrial.

Precision treatment with artificial intelligence assisted subtyping enhances therapeutic efficacy in HR+/HER2- breast cancer: The LINUXtrial.

Journal: Cancer cell

Published: March 08, 2025

Cell Surface-Confined DNAzyme Coordination-Facilitated Logical Engineering for Precise Cell Identification.

Cell Surface-Confined DNAzyme Coordination-Facilitated Logical Engineering for Precise Cell Identification.

Journal: Advanced materials (Deerfield Beach, Fla.)

Published: March 04, 2025

Homotypic membrane-powered electrochemical microfluidic analysis of extracellular vesicles for precise cancer diagnosis.

Homotypic membrane-powered electrochemical microfluidic analysis of extracellular vesicles for precise cancer diagnosis.

Journal: Nature communications

Published: March 03, 2025

HEBP2-governed glutamine competition between tumor and macrophages dictates immunotherapy efficacy in triple-negative breast cancer.

HEBP2-governed glutamine competition between tumor and macrophages dictates immunotherapy efficacy in triple-negative breast cancer.

Journal: Cell metabolism

Published: February 28, 2025

Showing 1-12 of 67

Last Updated: 09/26/2026